Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Alkermes plc.ALKS · Entity 2392 | Director | May 20, 2026 | May 22, 2026 |
| Endo International plcENDP · Entity 124463 | Director | June 11, 2021 | June 15, 2021 |
| PROTHENA CORP PUBLIC LTD COPRTA · Entity 2375 | Director | May 15, 2026 | May 16, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Alkermes plc.
Report date May 20, 2026 · Filed May 22, 2026 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Non Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $36.98 · Expires 2036-05-20 | Direct | 11,538 |
Reported balance
After 2026-05-20 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2026-05-20 · Grant · Acquired 11,538 · Balance 11,538 F1: Shares subject to the award vest (and if applicable, become exercisable) in full on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual general meeting of shareholders that occurs at least 50 weeks after the date of grant. F2: This amendment is being filed to reflect the vesting terms applicable to this award, which were reported incorrectly on the original Form 4. The correct vesting schedule is set forth in Footnote 1 above. |
| Restricted Stock Unit AwardSEC Table II · derivative / convertible security | Direct | 5,409 |
Reported balance
After 2026-05-20 transaction · row 2
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 2 · 2026-05-20 · Grant · Acquired 5,409 · Balance 5,409 F3: Each restricted stock unit represents a contingent right to receive one ordinary share. F1: Shares subject to the award vest (and if applicable, become exercisable) in full on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual general meeting of shareholders that occurs at least 50 weeks after the date of grant. F2: This amendment is being filed to reflect the vesting terms applicable to this award, which were reported incorrectly on the original Form 4. The correct vesting schedule is set forth in Footnote 1 above. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares subject to the award vest (and if applicable, become exercisable) in full on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual general meeting of shareholders that occurs at least 50 weeks after the date of grant.
F2: This amendment is being filed to reflect the vesting terms applicable to this award, which were reported incorrectly on the original Form 4. The correct vesting schedule is set forth in Footnote 1 above.
F3: Each restricted stock unit represents a contingent right to receive one ordinary share.
Endo International plc
Report date June 11, 2021 · Filed June 15, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 100,034 |
Ending reported balance
After 2021-06-11 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2021-06-11 · Grant · Acquired 47,924 · Balance 124,954 F1: These ordinary shares were granted to Mr. Cooke on June 11, 2021 in consideration of his services on Endo International plc's Board of Directors. Row 2 · 2021-06-11 · Tax withholding · Disposed 24,920 · Balance 100,034 F2: These shares represent ordinary shares withheld by Endo International plc to satisfy Mr. Cooke's tax withholding obligations on shares acquired on June 11, 2021. |
Filing footnotes · ownership attribution and instrument terms
F1: These ordinary shares were granted to Mr. Cooke on June 11, 2021 in consideration of his services on Endo International plc's Board of Directors.
F2: These shares represent ordinary shares withheld by Endo International plc to satisfy Mr. Cooke's tax withholding obligations on shares acquired on June 11, 2021.
PROTHENA CORP PUBLIC LTD CO
Report date May 15, 2026 · Filed May 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.76 · Expires 2036-05-15 | Direct | 27,000 |
Reported balance
After 2026-05-15 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-15 · Grant · Acquired 27,000 · Balance 27,000 F1: The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2027 of the Issuer's shareholders, assuming continuous service as a director until such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2027 of the Issuer's shareholders, assuming continuous service as a director until such vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 20, 2021 Filed May 21, 2021 20:34 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 6,104 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-017785 · form4.xml · nonDerivative · entry 1 Cooke Shane · CIK 0001524823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,976 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 19, 2021 Filed May 21, 2021 21:06 UTC | PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 | GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $23.97 | $0.00 |
DisclosureSEC source: 0001567619-21-010962 · doc1.xml · derivative · entry 1 Cooke Shane · CIK 0001524823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Ordinary Shares · 15,000 shares Expires 2031-05-19 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2022 of the Issuer's shareholders, assuming continuous service as a director until such vesting date. Read SEC document |
| March 15, 2021 Filed Mar 15, 2021 20:36 UTC | Endo International plc ENDP · Entity 124463 | SaleOrdinary Shares | 17,290 | $8.65 | $149,558.50 |
DisclosureSEC source: 0001593034-21-000028 · wf-form4_161584052668370.xml · nonDerivative · entry 1 Cooke Shane · CIK 0001524823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,030 Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:45 UTC | PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 | GrantEmployee Stock Option (Right to Buy) · Derivative | 6,315 | Not disclosed Strike: $22.85 | Not disclosed |
DisclosureSEC source: 0001567619-21-004316 · doc1.xml · derivative · entry 6 Cooke Shane · CIK 0001524823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,315 Underlying: Ordinary Shares · 6,315 shares Expires 2027-05-18 F4 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 12,000 of the issuer's ordinary shares granted to the reporting person on May 18, 2017. In exchange, the reporting person received a replacement option, for 6,315 ordinary shares, having an exercise price of $22.85 per ordinary share. F2 · derivative.exercise_date: The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:45 UTC | PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 | Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 12,000 | Not disclosed Strike: $56.23 | Not disclosed |
DisclosureSEC source: 0001567619-21-004316 · doc1.xml · derivative · entry 5 Cooke Shane · CIK 0001524823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 12,000 shares Expires 2027-05-18 F4 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 12,000 of the issuer's ordinary shares granted to the reporting person on May 18, 2017. In exchange, the reporting person received a replacement option, for 6,315 ordinary shares, having an exercise price of $22.85 per ordinary share. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:45 UTC | PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 | GrantEmployee Stock Option (Right to Buy) · Derivative | 8,426 | Not disclosed Strike: $22.85 | Not disclosed |
DisclosureSEC source: 0001567619-21-004316 · doc1.xml · derivative · entry 4 Cooke Shane · CIK 0001524823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,426 Underlying: Ordinary Shares · 8,426 shares Expires 2026-05-20 F3 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 15,000 of the issuer's ordinary shares granted to the reporting person on May 20, 2016. In exchange, the reporting person received a replacement option, for 8,426 ordinary shares, having an exercise price of $22.85 per ordinary share. F2 · derivative.exercise_date: The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:45 UTC | PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 | Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 15,000 | Not disclosed Strike: $42.50 | Not disclosed |
DisclosureSEC source: 0001567619-21-004316 · doc1.xml · derivative · entry 3 Cooke Shane · CIK 0001524823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 15,000 shares Expires 2026-05-20 F3 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 15,000 of the issuer's ordinary shares granted to the reporting person on May 20, 2016. In exchange, the reporting person received a replacement option, for 8,426 ordinary shares, having an exercise price of $22.85 per ordinary share. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:45 UTC | PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 | GrantEmployee Stock Option (Right to Buy) · Derivative | 9,803 | Not disclosed Strike: $22.85 | Not disclosed |
DisclosureSEC source: 0001567619-21-004316 · doc1.xml · derivative · entry 2 Cooke Shane · CIK 0001524823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,803 Underlying: Ordinary Shares · 9,803 shares Expires 2025-05-22 F1 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 15,000 of the issuer's ordinary shares granted to the reporting person on May 22, 2015. In exchange, the reporting person received a replacement option, for 9,803 ordinary shares, having an exercise price of $22.85 per ordinary share. F2 · derivative.exercise_date: The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:45 UTC | PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 | Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 15,000 | Not disclosed Strike: $34.04 | Not disclosed |
DisclosureSEC source: 0001567619-21-004316 · doc1.xml · derivative · entry 1 Cooke Shane · CIK 0001524823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 15,000 shares Expires 2025-05-22 F1 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 15,000 of the issuer's ordinary shares granted to the reporting person on May 22, 2015. In exchange, the reporting person received a replacement option, for 9,803 ordinary shares, having an exercise price of $22.85 per ordinary share. Read SEC document |
| December 02, 2020 Filed Dec 4, 2020 21:30 UTC | Alkermes plc. ALKS · Entity 2392 | GrantRestricted Stock Unit Award · Derivative | 5,578 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-030570 · form4.xml · derivative · entry 2 Cooke Shane · CIK 0001524823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,578 Underlying: Ordinary Shares · 5,578 shares Expires not disclosed F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in full on 12/2/2021. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in full on 12/2/2021. Read SEC document |
| December 02, 2020 Filed Dec 4, 2020 21:30 UTC | Alkermes plc. ALKS · Entity 2392 | GrantNon Qualified Stock Option (Right to Buy) · Derivative | 11,509 | $0.00 Strike: $18.82 | $0.00 |
DisclosureSEC source: 0001127602-20-030570 · form4.xml · derivative · entry 1 Cooke Shane · CIK 0001524823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,509 Underlying: Ordinary Shares · 11,509 shares Expires 2030-12-02 F1 · derivative.exercise_date: This option becomes exercisable in full on 12/2/2021. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 20:14 UTC | Endo International plc ENDP · Entity 124463 | Tax withholdingOrdinary Shares | 13,265 | $3.43 | $45,498.95 |
DisclosureSEC source: 0001593034-20-000055 · wf-form4_159233846796168.xml · nonDerivative · entry 2 Cooke Shane · CIK 0001524823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,320 F2 · kind: These shares represent ordinary shares withheld by Endo International plc to satisfy Mr. Cooke's tax withholding obligations on shares acquired on June 12, 2020. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 20:14 UTC | Endo International plc ENDP · Entity 124463 | GrantOrdinary Shares | 25,511 | $0.00 | $0.00 |
DisclosureSEC source: 0001593034-20-000055 · wf-form4_159233846796168.xml · nonDerivative · entry 1 Cooke Shane · CIK 0001524823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,585 F1 · kind: These ordinary shares were granted to Mr. Cooke on June 12, 2020 in consideration of his services on Endo International plc's Board of Directors. Read SEC document |
| May 20, 2020 Filed May 22, 2020 20:19 UTC | Alkermes plc. ALKS · Entity 2392 | GrantRestricted Stock Unit Award · Derivative | 6,104 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-017762 · form4.xml · derivative · entry 2 Cooke Shane · CIK 0001524823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,104 Underlying: Ordinary Shares · 6,104 shares Expires not disclosed F1 · shares: This option and restricted stock unit award together represent 50% of the approved value of the non-employee director annual equity grant. The remaining portion of such grant has been delayed, and is subject to downward adjustment, due to the uncertainty posed by the COVID-19 pandemic. F3 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in full on 5/20/2021. F3 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in full on 5/20/2021. Read SEC document |
| May 20, 2020 Filed May 22, 2020 20:19 UTC | Alkermes plc. ALKS · Entity 2392 | GrantNon Qualified Stock Option (Right to Buy) · Derivative | 12,823 | $0.00 Strike: $16.85 | $0.00 |
DisclosureSEC source: 0001127602-20-017762 · form4.xml · derivative · entry 1 Cooke Shane · CIK 0001524823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,823 Underlying: Ordinary Shares · 12,823 shares Expires 2030-05-20 F1 · shares: This option and restricted stock unit award together represent 50% of the approved value of the non-employee director annual equity grant. The remaining portion of such grant has been delayed, and is subject to downward adjustment, due to the uncertainty posed by the COVID-19 pandemic. F2 · derivative.exercise_date: This option becomes exercisable in full on 5/20/2021. Read SEC document |
| May 20, 2020 Filed May 22, 2020 20:38 UTC | PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 | GrantStock Option (Right to Buy) · Derivative | 17,500 | $0.00 Strike: $11.33 | $0.00 |
DisclosureSEC source: 0001567619-20-011031 · doc1.xml · derivative · entry 1 Cooke Shane · CIK 0001524823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Underlying: Ordinary Shares · 17,500 shares Expires 2030-05-20 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2021 of the Issuer's shareholders, assuming continuous service as a director until such vesting date. Read SEC document |
| June 12, 2019 Filed Jun 14, 2019 23:29 UTC | Endo International plc ENDP · Entity 124463 | Tax withholdingOrdinary Shares | 27,982 | $4.46 | $124,799.72 |
DisclosureSEC source: 0001209191-19-037299 · doc4.xml · nonDerivative · entry 2 Cooke Shane · CIK 0001524823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,074 F2 · kind: These shares represent ordinary shares withheld by Endo International plc to satisfy Mr. Cooke's tax withholding obligations on shares acquired on June 12, 2019. Read SEC document |
| June 12, 2019 Filed Jun 14, 2019 23:29 UTC | Endo International plc ENDP · Entity 124463 | GrantOrdinary Shares | 53,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-037299 · doc4.xml · nonDerivative · entry 1 Cooke Shane · CIK 0001524823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,056 F1 · kind: These ordinary shares were granted to Mr. Cooke on June 12, 2019 in consideration of his services on Endo International plc's Board of Directors. Read SEC document |
| May 22, 2019 Filed May 23, 2019 22:28 UTC | Alkermes plc. ALKS · Entity 2392 | GrantNon Qualified Stock Option (Right to Buy) · Derivative | 22,400 | $0.00 Strike: $25.04 | $0.00 |
DisclosureSEC source: 0001127602-19-019714 · form4.xml · derivative · entry 1 Cooke Shane · CIK 0001524823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,400 Underlying: Ordinary Shares · 22,400 shares Expires 2029-05-22 F1 · derivative.exercise_date: This option becomes exercisable in full on 5/22/2020. Read SEC document |
| May 22, 2019 Filed May 24, 2019 20:09 UTC | PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 | GrantStock Option (Right to Buy) · Derivative | 17,500 | $0.00 Strike: $9.23 | $0.00 |
DisclosureSEC source: 0001567619-19-012077 · doc1.xml · derivative · entry 1 Cooke Shane · CIK 0001524823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Underlying: Ordinary Shares · 17,500 shares Expires 2029-05-22 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day prior to the annual general meeting in 2020 of the Issuer's shareholders, assuming continuous service as a director until such vesting date. Read SEC document |
| June 08, 2018 Filed Jun 12, 2018 20:07 UTC | Endo International plc ENDP · Entity 124463 | Tax withholdingOrdinary Shares | 16,271 | $7.67 | $124,798.57 |
DisclosureSEC source: 0001209191-18-037209 · doc4.xml · nonDerivative · entry 2 Cooke Shane · CIK 0001524823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,244 F2 · kind: These shares represent ordinary shares withheld by Endo International plc to satisfy Mr. Cooke's tax withholding obligations on shares acquired on June 8, 2018. Read SEC document |
| June 08, 2018 Filed Jun 12, 2018 20:07 UTC | Endo International plc ENDP · Entity 124463 | GrantOrdinary Shares | 31,291 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-037209 · doc4.xml · nonDerivative · entry 1 Cooke Shane · CIK 0001524823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,515 F1 · kind: These ordinary shares were granted to Mr. Cooke on June 8, 2018 in consideration of his services on Endo International plc's Board of Directors. Read SEC document |
| May 23, 2018 Filed May 24, 2018 22:10 UTC | Alkermes plc. ALKS · Entity 2392 | GrantNon Qualified Stock Option (Right to Buy) · Derivative | 26,000 | $0.00 Strike: $45.64 | $0.00 |
DisclosureSEC source: 0001127602-18-018844 · form4.xml · derivative · entry 2 Cooke Shane · CIK 0001524823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,000 Underlying: Ordinary Shares · 26,000 shares Expires 2028-05-23 F2 · derivative.exercise_date: This option vests in 3 equal annual installments commencing on 5/23/19. Read SEC document |
| May 23, 2018 Filed May 24, 2018 22:10 UTC | Alkermes plc. ALKS · Entity 2392 | GrantNon Qualified Stock Option (Right to Buy) · Derivative | 17,500 | $0.00 Strike: $45.64 | $0.00 |
DisclosureSEC source: 0001127602-18-018844 · form4.xml · derivative · entry 1 Cooke Shane · CIK 0001524823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Underlying: Ordinary Shares · 17,500 shares Expires 2028-05-23 F1 · derivative.exercise_date: This option becomes exercisable in full on 5/23/19. Read SEC document |
| May 16, 2018 Filed May 18, 2018 20:15 UTC | PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 | GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $16.43 | $0.00 |
DisclosureSEC source: 0000899243-18-013413 · doc4.xml · derivative · entry 1 Cooke Shane · CIK 0001524823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Ordinary Shares · 12,000 shares Expires 2028-05-16 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day prior to the annual general meeting in 2019 of the Issuer's shareholders, assuming continuous service as a director until such vesting date. Read SEC document |
| March 03, 2018 Filed Mar 5, 2018 22:55 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionRestricted Stock Unit Award · Derivative | 5,250 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-010205 · form4.xml · derivative · entry 6 Cooke Shane · CIK 0001524823 · President, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 5,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This RSU award is fully vested in accordance with its terms. F2 · derivative.expiration_date: This RSU award is fully vested in accordance with its terms. Read SEC document |
| March 03, 2018 Filed Mar 5, 2018 22:55 UTC | Alkermes plc. ALKS · Entity 2392 | Tax withholdingOrdinary Shares | 2,730 | $60.05 | $163,936.50 |
DisclosureSEC source: 0001127602-18-010205 · form4.xml · nonDerivative · entry 4 Cooke Shane · CIK 0001524823 · President, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,872 Read SEC document |
| March 03, 2018 Filed Mar 5, 2018 22:55 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 5,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-010205 · form4.xml · nonDerivative · entry 3 Cooke Shane · CIK 0001524823 · President, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,602 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 22:55 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionRestricted Stock Unit Award · Derivative | 7,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-010205 · form4.xml · derivative · entry 5 Cooke Shane · CIK 0001524823 · President, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Ordinary Shares · 7,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 3/1/2017. F1 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 3/1/2017. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 22:55 UTC | Alkermes plc. ALKS · Entity 2392 | Tax withholdingOrdinary Shares | 3,640 | $57.41 | $208,972.40 |
DisclosureSEC source: 0001127602-18-010205 · form4.xml · nonDerivative · entry 2 Cooke Shane · CIK 0001524823 · President, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,352 Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 22:55 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 7,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-010205 · form4.xml · nonDerivative · entry 1 Cooke Shane · CIK 0001524823 · President, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,992 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2018 Filed Feb 28, 2018 22:54 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionRestricted Stock Unit Award · Derivative | 4,425 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-009193 · form4.xml · derivative · entry 3 Cooke Shane · CIK 0001524823 · President, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,425 Underlying: Ordinary Shares · 4,425 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/26/2016. F1 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/26/2016. Read SEC document |
| February 26, 2018 Filed Feb 28, 2018 22:54 UTC | Alkermes plc. ALKS · Entity 2392 | Tax withholdingOrdinary Shares | 2,301 | $58.12 | $133,734.12 |
DisclosureSEC source: 0001127602-18-009193 · form4.xml · nonDerivative · entry 2 Cooke Shane · CIK 0001524823 · President, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,992 Read SEC document |
| February 26, 2018 Filed Feb 28, 2018 22:54 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 4,425 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-009193 · form4.xml · nonDerivative · entry 1 Cooke Shane · CIK 0001524823 · President, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,293 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2018 Filed Feb 21, 2018 22:51 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionRestricted Stock Unit Award · Derivative | 4,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-007598 · form4.xml · derivative · entry 3 Cooke Shane · CIK 0001524823 · President, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,500 Underlying: Ordinary Shares · 4,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/17/18. F1 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/17/18. Read SEC document |
| February 17, 2018 Filed Feb 21, 2018 22:51 UTC | Alkermes plc. ALKS · Entity 2392 | Tax withholdingOrdinary Shares | 2,340 | $67.26 | $157,388.40 |
DisclosureSEC source: 0001127602-18-007598 · form4.xml · nonDerivative · entry 2 Cooke Shane · CIK 0001524823 · President, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,868 Read SEC document |
| February 17, 2018 Filed Feb 21, 2018 22:51 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 4,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-007598 · form4.xml · nonDerivative · entry 1 Cooke Shane · CIK 0001524823 · President, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,208 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2018 Filed Feb 2, 2018 23:07 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 72,793 | $0.00 Strike: $16.55 | $0.00 |
DisclosureSEC source: 0001127602-18-003852 · form4.xml · derivative · entry 4 Cooke Shane · CIK 0001524823 · President, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Ordinary Shares · 72,793 shares Expires 2022-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 5/19/17. F5 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| February 02, 2018 Filed Feb 2, 2018 23:07 UTC | Alkermes plc. ALKS · Entity 2392 | SaleOrdinary Shares | 19,504 | $61.03 | $1,190,292.06 |
DisclosureSEC source: 0001127602-18-003852 · form4.xml · nonDerivative · entry 3 Cooke Shane · CIK 0001524823 · President, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,708 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 5/19/17. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $61.00 to $61.36. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| February 02, 2018 Filed Feb 2, 2018 23:07 UTC | Alkermes plc. ALKS · Entity 2392 | SaleOrdinary Shares | 53,289 | $60.38 | $3,217,387.32 |
DisclosureSEC source: 0001127602-18-003852 · form4.xml · nonDerivative · entry 2 Cooke Shane · CIK 0001524823 · President, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,212 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 5/19/17. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.00 to $60.98. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| February 02, 2018 Filed Feb 2, 2018 23:07 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 72,793 | $16.55 | $1,204,724.15 |
DisclosureSEC source: 0001127602-18-003852 · form4.xml · nonDerivative · entry 1 Cooke Shane · CIK 0001524823 · President, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,501 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 5/19/17. Read SEC document |
| January 29, 2018 Filed Jan 30, 2018 02:55 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,300 | $0.00 Strike: $16.55 | $0.00 |
DisclosureSEC source: 0001127602-18-002896 · form4.xml · derivative · entry 6 Cooke Shane · CIK 0001524823 · President, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,793 Underlying: Ordinary Shares · 3,300 shares Expires 2022-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 5/19/17. F4 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| January 29, 2018 Filed Jan 30, 2018 02:55 UTC | Alkermes plc. ALKS · Entity 2392 | SaleOrdinary Shares | 3,300 | $60.00 | $198,000.00 |
DisclosureSEC source: 0001127602-18-002896 · form4.xml · nonDerivative · entry 4 Cooke Shane · CIK 0001524823 · President, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,708 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 5/19/17. Read SEC document |
| January 29, 2018 Filed Jan 30, 2018 02:55 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 3,300 | $16.55 | $54,615.00 |
DisclosureSEC source: 0001127602-18-002896 · form4.xml · nonDerivative · entry 3 Cooke Shane · CIK 0001524823 · President, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,008 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 5/19/17. Read SEC document |
| January 26, 2018 Filed Jan 30, 2018 02:55 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,700 | $0.00 Strike: $16.55 | $0.00 |
DisclosureSEC source: 0001127602-18-002896 · form4.xml · derivative · entry 5 Cooke Shane · CIK 0001524823 · President, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,093 Underlying: Ordinary Shares · 1,700 shares Expires 2022-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 5/19/17. F4 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| January 26, 2018 Filed Jan 30, 2018 02:55 UTC | Alkermes plc. ALKS · Entity 2392 | SaleOrdinary Shares | 1,700 | $60.02 | $102,027.88 |
DisclosureSEC source: 0001127602-18-002896 · form4.xml · nonDerivative · entry 2 Cooke Shane · CIK 0001524823 · President, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,708 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 5/19/17. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.00 to $60.09. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| January 26, 2018 Filed Jan 30, 2018 02:55 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 1,700 | $16.55 | $28,135.00 |
DisclosureSEC source: 0001127602-18-002896 · form4.xml · nonDerivative · entry 1 Cooke Shane · CIK 0001524823 · President, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,408 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 5/19/17. Read SEC document |
| January 11, 2018 Filed Jan 16, 2018 23:30 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 6,207 | $0.00 Strike: $16.55 | $0.00 |
DisclosureSEC source: 0001127602-18-001881 · form4.xml · derivative · entry 3 Cooke Shane · CIK 0001524823 · President, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,793 Underlying: Ordinary Shares · 6,207 shares Expires 2022-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 5/19/17. F4 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| January 11, 2018 Filed Jan 16, 2018 23:30 UTC | Alkermes plc. ALKS · Entity 2392 | SaleOrdinary Shares | 6,207 | $60.22 | $373,809.13 |
DisclosureSEC source: 0001127602-18-001881 · form4.xml · nonDerivative · entry 2 Cooke Shane · CIK 0001524823 · President, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,708 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 5/19/17. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.00 to $60.46. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| January 11, 2018 Filed Jan 16, 2018 23:30 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 6,207 | $16.55 | $102,725.85 |
DisclosureSEC source: 0001127602-18-001881 · form4.xml · nonDerivative · entry 1 Cooke Shane · CIK 0001524823 · President, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,915 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 5/19/17. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.